Aggregation kinetic and temperature optimum of an EDTA-dependent pseudothrombocytopenia

Articles in the same Issue

1. 10.1515/cclm-2020-frontmatter1
2. Mario Plebani turns 70
3. Editorial
4. Measurement uncertainty and the importance of correlation
5. Reviews
6. Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis
7. The emerging role of cell senescence in atherosclerosis
8. Mini Review
9. Minimum retesting intervals in practice: 10 years experience
10. Opinion Paper
11. Cardiotoxic effects and myocardial injury: the search for a more precise definition of drug cardiotoxicity
12. EFLM Papers
13. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
14. Thoughts and expectations of young professionals about the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
15. Guidelines and Recommendations
16. Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers
17. Genetics and Molecular Diagnostics
18. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers
19. General Clinical Chemistry and Laboratory Medicine
20. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care
21. Evaluation of serum electrolytes measurement through the 6-year trueness verification program in China
22. Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results
23. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data
24. Effects of calcium dobesilate (CaD) interference on serum creatinine measurements: a national External Quality Assessment (EQA)-based educational survey of drug-laboratory test interactions
25. Mass spectrometric sample identification with indicator compounds introduced via labeled sample tubes
26. Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab
27. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG)
28. Analytical evaluation of four faecal immunochemistry tests for haemoglobin
29. Reference Values and Biological Variations
30. Study of total error specifications of lymphocyte subsets enumeration using China National EQAS data and Biological Variation Data Critical Appraisal Checklist (BIVAC)-compliant publications
31. Mass spectrometric quantification of urinary 6-sulfatoxymelatonin: age-dependent excretion and biological variation
32. Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein
33. Hematology and Coagulation
34. Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening
35. Cardiovascular Diseases
36. Analysis of B-type natriuretic peptide impurities using label-free data-independent acquisition mass spectrometry technology
37. Diabetes
38. Hemoglobin variants in southern China: results obtained during the measurement of glycated hemoglobin in a large population
39. Potential of MALDI-TOF mass spectrometry to overcome the interference of hemoglobin variants on HbA_1c measurement
40. Acknowledgment
41. Acknowledgment
42. Letter to the Editors
43. Measurement uncertainty estimation for derived biological quantities
44. Non-reproducible cardiac troponin results occurring with a particular reagent lot
45. Successfully meeting analytical expectations for the fast 0/1-h algorithm for NSTEMI by internal control procedures for cardiac troponin T
46. Performance of perpendicular drop versus tangent skimming gating of M-protein in proficiency testing challenges
47. Analytical evaluation of Reebio procalcitonin latex-enhanced immunoturbidimetric assay on the HITACHI Labospect 008AS
48. Assessment of intraindividual agreement in prolactin results after post-polyethylene glycol precipitation test for the estimation of macroprolactin. Should the precipitation procedure be repeated in the same patient?
49. Aggregation kinetic and temperature optimum of an EDTA-dependent pseudothrombocytopenia